The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Transgenic Mice Overexpressing Glycogen Synthase Kinase 3β: A Putative Model of Hyperactivity and Mania
Open accessAbstract
Lithium is used as treatment for bipolar disorder with particular efficacy in the treatment of mania. Lithium inhibits glycogen synthase kinase 3beta (GSK-3beta) directly or indirectly via stimulation of the kinase Akt-1. We therefore investigated the possibility that transgenic mice overexpressing GSK-3beta could be of relevance to model bipolar disorder. Transgenic mice showed hypophagia, an increased general locomotor activity, and decreased habituation as assessed in an open field, an increased acoustic startle response, and again decreased habituation. The forced swim test revealed a reduced immobility in transgenic mice, but this is probably related to the hyperactivity of the animals. There were no differences in baseline and stress-induced increases of plasma adrenocorticotrophic hormone and corticosterone levels. Molecular analysis suggests compensatory mechanisms in the striatum of these transgenic mice for the overload of active GSK-3beta by dimming the endogenous GSK-3beta signaling pathway via upregulation of Akt-1 expression. Brain-derived neurotrophic factor protein levels were increased in the hippocampus of the transgenic mice. This suggests some kind of compensatory mechanism to the observed reduction in brain weight, which has been related previously to a reduced size of the somatodendritic compartment. Together, in mice overexpressing GSK-3beta, specific intracellular signaling pathways are affected, which is accompanied by altered plasticity processes and increased activity and reactivity, whereas habituation processes seem to be decreased. The behavioral observations led to the suggestion that the model at hand recapitulates hyperactivity as observed in the manic phase of bipolar disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“transgenic mice overexpressing the circadian modulator, GSK3β, are hyperactive, have reduced immobility in the forced swim test (indicative of lower depression-like behavior), and an increased startle response (Prickaerts et al., 2006).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Prickaerts et al., 2006
In the citing paper
“transgenic mice overexpressing the circadian modulator, GSK3β, are hyperactive, have reduced immobility in the forced swim test (indicative of lower depression-like behavior), and an increased startle response (Prickaerts et al., 2006).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Prickaerts et al., 2006
In the citing paper
“transgenic mice overexpressing the circadian modulator, GSK3β, are hyperactive, have reduced immobility in the forced swim test (indicative of lower depression-like behavior), and an increased startle response (Prickaerts et al., 2006).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Prickaerts et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,334
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,440
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Koch, M. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00098-7 · Cited by 1,287
Nibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206
Prestimulus Effects on Human Startle Reflex in Normals and Schizophrenics
BRAFF, D. L., Stone, C., Callaway, E., Geyer, M. A., Glick, I. D., & Bali, L. (1978) · Psychophysiology · doi:10.1111/j.1469-8986.1978.tb01390.x · Cited by 1,171
Neural and developmental actions of lithium: A unifying hypothesis
Berridge, M. J., Downes, C. P., & Hanley, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90026-3 · Cited by 1,013
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 1,005
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 914
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885
Beaulieu, J., Sotnikova, T. D., Yao, W., Kockeritz, L. K., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 815
Greengard, P., Allen, P. B., & Nairn, A. C. (1999) · Neuron · doi:10.1016/s0896-6273(00)80798-9 · Cited by 761
Beck, K. D., Powell-Braxtont, L., Widmer, H.-R., Valverde, J., & Hefti, F. (1995) · Neuron · doi:10.1016/0896-6273(95)90216-3 · Cited by 636
Enhancement of Hippocampal Neurogenesis by Lithium
Chen, G., Rajkowska, G., Du, F., Seraji‐Bozorgzad, N., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751729.x · Cited by 603
Both the Establishment and the Maintenance of Neuronal Polarity Require Active Mechanisms
Jiang, H., Guo, W., Liang, X., & Rao, Y. (2005) · Cell · doi:10.1016/j.cell.2004.12.033 · Cited by 516
Psychiatric and Medical Comorbidities of Bipolar Disorder
Krishnan, K. R. R. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000151489.36347.18 · Cited by 502
Hyperactivity and impaired response habituation in hyperdopaminergic mice
Zhuang, X., Oosting, R. S., Jones, S. R., Gainetdinov, R. R., Miller, G. W., Caron, M. G., & Hen, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1982 · Cited by 500
Andjelković, M., Jakubowicz, T., Cron, P. D., Ming, X., Han, J. W., & Hemmings, B. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5699 · Cited by 497
Insulin Activation of Phosphatidylinositol 3-Kinase in the Hypothalamic Arcuate Nucleus
Niswender, K. D., Morrison, C. D., Clegg, D. J., Olson, R., Baskin, D. G., Myers, M. G., Seeley, R. J., & Schwartz, M. W. (2003) · Diabetes · doi:10.2337/diabetes.52.2.227 · Cited by 476
Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 382
Wagner, J. P., Black, I. B., & DiCicco-Bloom, E. M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-06006.1999 · Cited by 374
Lithium Induces Rapid Relief of Depression in Tricyclic Antidepressant Drug Non-Responders
de Montigny, C., Grünberg, F., Mayer, A., & Deschenes, J.-P. (1981) · The British Journal of Psychiatry · doi:10.1192/bjp.138.3.252 · Cited by 367
Spittaels, K., den Haute, C. V., Dorpe, J. V., Geerts, H., Mercken, M. H., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006219200 · Cited by 324
Gould, T. D., Einat, H., Bhat, R. V., & Manji, H. K. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004535 · Cited by 314
The role of dopamine in the mechanism of action of antidepressant drugs
D’Aquila, P. S., Collu, M., Gessa, G. L., & Serra, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00566-5 · Cited by 289
Kaidanovich‐Beilin, O., Milman, A., Weizman, A., Pick, C. G., & Eldar-Finkelman, H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.008 · Cited by 276
Ralph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G., & Geyer, M. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00305.2001 · Cited by 271
Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania
Perry, W., Minassian, A., Feifel, D., & Braff, D. L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01184-2 · Cited by 260
Glycogen synthase kinase‐3β, mood stabilizers, and neuroprotection
Li, X., Bijur, G. N., & Jope, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.40201.x · Cited by 240
Swerdlow, N. R., Mansbach, R. S., Geyer, M. A., Pulvirenti, L., Koob, G. F., & BRAFF, D. L. (1990) · Psychopharmacology · doi:10.1007/bf02244616 · Cited by 235
In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3
Gould, T. D., Chen, G. J., & Manji, H. K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300283 · Cited by 217
Insulin-like growth factor 1 regulates developing brain glucose metabolism
Cheng, C. M., Reinhardt, R. R., Lee, W.-H., Joncas, G., Patel, S. C., & Bondy, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170008497 · Cited by 204
BDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents
Mai, L., Jope, R. S., & Li, X. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00939.x · Cited by 197
Body weight is regulated by the brain: a link between feeding and emotion
Kishi, T., & Elmquist, J. K. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001638 · Cited by 183
Jacobsen, J. P. R., & Mørk, A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.065 · Cited by 182
Glucocorticoids and depression
Steckler, T., Holsboer, F., & Reul, J. M. H. M. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0046 · Cited by 160
Gould, T. D., Zarate, C. A., & Manji, H. K. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0103 · Cited by 159
Perspectives for the development of animal models of bipolar disorder
Machado-Vieira, R., Kapczinski, F., & Soares, J. C. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.10.015 · Cited by 158
Novelty Seeking and Stereotypic Activation of Behavior in Mice with Disruption of the Dat1 Gene
Pogorelov, V. M., Rodriguiz, R. M., Insco, M. L., Caron, M. G., & Wetsel, W. C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300724 · Cited by 151
Glycogen Synthase Kinase 3: A Target for Novel Mood Disorder Treatments
Gould, T. D., & Manji, H. K. (2006) · Wiley eBooks · doi:10.1002/0470052171.ch7 · Cited by 134
Role of dopamine in prepulse inhibition of acoustic startle
Zhang, J., Forkstam, C., Engel, J., & Svensson, L. (2000) · Psychopharmacology · doi:10.1007/s002130000369 · Cited by 129
A concise review on the therapeutics of obesity
Bray, G. A. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00424-x · Cited by 126
Ralph, R. J., Paulus, M. P., Zhuang, X., Hen, R., & Geyer, M. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01489-0 · Cited by 119
Spittaels, K., den Haute, C. V., Dorpe, J. V., Terwel, D., Vandezande, K., Lasrado, R., Bruynseels, K., Irizarry, M. C., Verhoye, M., Lint, J. V., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00236-1 · Cited by 103
Salas, T. R., Reddy, S. A. G., Clifford, J. L., Davis, R. J., Kikuchi, A., Lippman, S. M., & Menter, D. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302972200 · Cited by 70
Scheepens, A., van de Waarenburg, M. P. H., van den Hove, D., & Blanco, C. E. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.043414 · Cited by 65
Signal Transduction and Genes-to-Behaviors Pathways in Psychiatric Diseases
Manji, H. K., Gottesman, I. I., & Gould, T. D. (2003) · Science Signaling · doi:10.1126/stke.2003.207.pe49 · Cited by 64
Glycogen synthase kinase-3 as drug target: From wallflower to center of attention
Wauwe, J. V., & Haefner, B. (2003) · Drug News & Perspectives · doi:10.1358/dnp.2003.16.9.829337 · Cited by 60
Klamer, D., P�lsson, E., Revesz, A., Engel, J. A., & Svensson, L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1901-z · Cited by 56
Dysregulation of Striatal Dopamine Signaling by Amphetamine Inhibits Feeding by Hungry Mice
Cannon, C. M., Abdallah, L., Tecott, L. H., During, M. J., & Palmiter, R. D. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.009 · Cited by 54
The effect of lithium administration in animal models of depression: a short review
Redrobe, J. P., & Bourin, M. (1999) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1999.tb00348.x · Cited by 32
[Schizophrenia and eating disorders].
Foulon, C. (2004) · PubMed · Cited by 29
Localization, physiology, and modulation of a molluskan dopaminergic synapse
Magoski, N. S., & Bulloch, A. G. M. (1997) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199709)33:3 · Cited by 19
Lewis, M. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00213-2 · Cited by 12
Animal Models for the Symptoms of Mania
Lyon, M. (2003) · Humana Press eBooks · doi:10.1385/0-89603-198-5:197 · Cited by 8
Flagged first, then by citations
Cited by
Sorted by citations
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
Circadian genes, rhythms and the biology of mood disorders
McClung, C. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.003 · Cited by 666
Dopamine receptors – IUPHAR R eview 13
Beaulieu, J., Espinoza, S., & Gainetdinov, R. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12906 · Cited by 561
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J., Gainetdinov, R. R., & Caron, M. G. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 536
Metadata
- Authors
- Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A., & Steckler, T.
- Affiliations
- Janssen Research & Development (United States) (US)
- Corresponding author
- Steckler, Thomas
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-08-30
- Volume
- 26
- Issue
- 35
- Pages
- 9022-9029
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6675350
- OpenAlex
- W1963600261
- Cited by
- 341
- References
- 59
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 7 · 2023: 7 · 2022: 13 · 2021: 14 · 2020: 17 · 2019: 7 · 2018: 11 · 2017: 13 · 2016: 22 · 2015: 20 · 2014: 27 · 2013: 27 · 2012: 21
- FWCI
- 11.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by-nc-sa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- European Commission
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- glycogen synthase kinase-3β, transgenic mice, hyperactivity, mania, bipolar disorder, lithium, AKT1, brain-derived neurotrophic factor, striatum, hippocampus, locomotor activity, acoustic startle response, habituation, ACTH, compensatory signaling, neuroplasticity
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Adrenocorticotropic Hormone, Animals, Bipolar Disorder, Corticosterone, Disease Models, Animal, DNA, Drinking, Eating, Female, Hippocampus, Hyperkinesis, Male, Mice, Transgenic, Motor Activity, Reflex, Startle, Swimming, Signal Transduction, Photoperiod, Brain-Derived Neurotrophic Factor, Glycogen Synthase Kinase 3, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
